EDGEWISE THERAPEUTICS INC's ticker is EWTX and the CUSIP is 28036F105. A total of 86 filers reported holding EDGEWISE THERAPEUTICS INC in Q1 2023. The put-call ratio across all filers is 3.56 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $34,790,858 | -26.1% | 6,071,703 | 0.0% | 2.57% | -29.3% |
| Q2 2023 | $47,055,698 | +16.2% | 6,071,703 | 0.0% | 3.64% | +36.1% |
| Q1 2023 | $40,498,259 | -25.4% | 6,071,703 | 0.0% | 2.67% | -21.2% |
| Q4 2022 | $54,281,025 | -9.1% | 6,071,703 | 0.0% | 3.39% | +19.0% |
| Q3 2022 | $59,746,000 | +34.3% | 6,071,703 | +8.7% | 2.85% | +30.1% |
| Q2 2022 | $44,474,000 | -17.9% | 5,587,207 | 0.0% | 2.19% | -23.4% |
| Q1 2022 | $54,196,000 | -36.5% | 5,587,207 | 0.0% | 2.86% | -29.3% |
| Q4 2021 | $85,373,000 | -8.0% | 5,587,207 | 0.0% | 4.04% | -15.7% |
| Q3 2021 | $92,748,000 | -22.2% | 5,587,207 | 0.0% | 4.80% | -9.3% |
| Q2 2021 | $119,175,000 | -34.4% | 5,587,207 | 0.0% | 5.29% | -29.5% |
| Q1 2021 | $181,584,000 | – | 5,587,207 | – | 7.50% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| New Leaf Venture Partners, L.L.C. | 1,553,661 | $8,902,478 | 11.43% |
| Novo Holdings A/S | 6,071,703 | $34,790,858 | 2.57% |
| Orbimed Advisors | 14,567,176 | $83,469,918 | 1.77% |
| Opaleye Management Inc. | 875,405 | $5,016,071 | 1.63% |
| Cormorant Asset Management, LP | 2,946,887 | $16,885,663 | 0.98% |
| DAFNA Capital Management LLC | 519,384 | $2,976,070 | 0.93% |
| EcoR1 Capital, LLC | 3,493,194 | $20,016,002 | 0.68% |
| Deep Track Capital, LP | 2,750,000 | $15,757,500 | 0.61% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 3,933,137 | $22,536,875 | 0.50% |
| Parkman Healthcare Partners LLC | 473,312 | $2,712,078 | 0.50% |